ImExHS Limited Stock

Equities

IME

AU0000023053

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. 12:50:40 2024-04-26 am EDT 5-day change 1st Jan Change
0.57 AUD +4.59% Intraday chart for ImExHS Limited +5.56% -14.93%
Sales 2024 * 24.41M 15.95M Sales 2025 * 30.87M 20.17M Capitalization 25.96M 16.95M
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 0.96 x
Net cash position 2024 * 2.49M 1.62M Net cash position 2025 * 7.91M 5.17M EV / Sales 2025 * 0.58 x
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees 400
Yield 2024 *
-
Yield 2025 *
-
Free-Float 36.94%
More Fundamentals * Assessed data
Dynamic Chart
1 day+4.59%
1 week+5.56%
Current month-1.72%
1 month+7.55%
3 months-9.52%
6 months-18.57%
Current year-14.93%
More quotes
1 week
0.55
Extreme 0.545
0.57
1 month
0.54
Extreme 0.54
0.60
Current year
0.50
Extreme 0.5
0.69
1 year
0.50
Extreme 0.5
0.70
3 years
0.40
Extreme 0.4
2.31
5 years
0.40
Extreme 0.4
3.75
10 years
0.40
Extreme 0.4
3.75
More quotes
Managers TitleAgeSince
Founder - -
Founder - -
Founder - -
Members of the board TitleAgeSince
Chairman 75 20-03-11
Director/Board Member 58 20-05-21
Founder - -
More insiders
Date Price Change Volume
24-04-26 0.57 +4.59% 2,769
24-04-24 0.545 +0.93% 2
24-04-19 0.54 -1.82% 6,564
24-04-18 0.55 -1.79% 16,375

Delayed Quote Australian S.E., April 26, 2024 at 12:50 am EDT

More quotes
IMEXHS Limited is an Australia-based provider of medical imaging software and radiology services in 18 countries, including Colombia, the United States and Australia. The Company develops software-as-a-service imaging solutions that includes a Picture Archiving and Communications System (PACS), a Radiology Information System (RIS), a Cardiology Information System (CIS) and an Anatomical Pathology Laboratory Information System (APLIS). Its solutions are cloud-based, vendor neutral and zero footprint, with no need for installed software. Its radiology services provide radiological diagnostic services to hospitals and medical facilities in Colombia and Spain using IMEXHS medical imaging software. The Company's services business also provides it with medical images and radiologists interpretation and reports to develop artificial intelligence (AI) tools. Its solutions include AQUILA - Radiology, ALULA - Pathology, ANTEROS - cardiology, artificial intelligence and advanced visualization.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.57 AUD
Average target price
1.5 AUD
Spread / Average Target
+163.16%
Consensus

Quarterly revenue - Rate of surprise